{"_id": "64ff8e088ed67004cfc73a84", "nctID": "NCT02973750", "booleanRepresentation": "{\n    \"$and\":[\n        {\n            \"$and\": [\n                {\n                    \"$or\": [\n                        {\n                            \"$and\": [\n                                {\"Histological or cytological diagnosis of high-grade serous ovarian, fallopian, or peritoneal cancer\"},\n                                {\"stage III or IV\"}\n                            ]\n                        },\n                        {\"In the opinion of investigator, highly suspicious stage III or IV ovarian, fallopian, or peritoneal cancer\"}\n                    ]\n                },\n                {\"At least one biopsiable lesion by CT/US or laparoscopy\"},\n                {\"Have not received previous treatment for ovarian cancer\"},\n                {\"Life expectancy of greater than 6 months\"},\n                {\"Eastern Cooperative Oncology Group (ECOG) performance status less than 3 (Karnofsky greater than 60%)\"},\n                {\"Must have adequate organ and marrow function\"},\n                {\"Deemed eligible for neo-adjuvant chemotherapy with carboplatin and paclitaxel and surgery by their oncologist\"},\n                {\"Women of child-bearing potential must agree to use adequate contraception prior to study entry and for the duration of study participation\"},\n                {\"Ability to understand and the willingness to sign a written informed consent document\"}\n            ]\n        },\n        {\n            \"$not\": {\n                \"$or\": [\n                    {\"Active second malignancy within last 2 years\"},\n                    {\"Prior treatment for ovarian cancer\"},\n                    {\"Potential participants with known brain metastases\"},\n                    {\"History of allergic reactions attributed to compounds of similar chemical or biologic composition to carboplatin and paclitaxel\"},\n                    {\"Known allergy to carboplatin, paclitaxel, or cremophor\"},\n                    {\"Uncontrolled concomitant illness including, but not limited to, ongoing or active infection, symptomatic congestive heart failure, unstable angina pectoris, cardiac arrhythmia, or psychiatric illness/social situations that would limit compliance with study requirements\"},\n                    {\"Women who are pregnant\"},\n                    {\"HIV-positive patients receiving combination anti-retroviral therapy\"}\n                ]\n            }\n        }\n    ]\n}"}